Skip to main content

Rockefeller University

!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Upcoming Event

[RESCHEDULED FOR 1/27/21] RiSI Diversity, Equity, Inclusion, and Justice Journal Club

The Diversity-Innovation Paradox in Science

Event Details

Type
Club Meetings
Open to
Public
Contact
Rochelle Shih
Phone
(702) 481-1788
Sponsor
Rochelle Shih
(702) 481-1788
rshih@rockefeller.edu

Add To Your Calendar

Related News

The immune system mounts a lasting defense after recovery from COVID-19

The study participants continued to improve their antibodies months after initial infection, potentially due to exposure to the remnants of the virus hidden in the gut.

The blood may hold clues to some of COVID-19’s most mysterious symptoms

COVID-19 causes a host of diverse complications, from lung inflammation to blood clots, heart failure, and brain fog. A team of scientists believes these attributes may have a single culprit—and that findings from research on Alzheimer’s disease might give them a leg up in finding it.

Rockefeller begins testing of new COVID-19 antibody drug in people

Patients in the clinical trial will receive two highly potent antibodies against SARS-CoV-2 discovered at the university. Designed to prevent people with early COVID-19 from developing severe disease, the treatment is urgently needed as hospitals continue to be inundated by repeated surges of infection, and mass vaccinations are still months away.

Related Events

| WEBINAR

Synthetic Lethality of Wnt Pathway Activation and Asparaginase for Cancer Therapy

| WEBINAR

Mechanisms of Transcriptional Regulation by Chromatin Adaptor Proteins

| WEBINAR

RNA Modifications: Dynamic Regulators of Protein Synthesis

Calendar of Events & Lectures

Browse upcoming and past Events and Lectures by keyword, program, date and type

Contact

Rochelle Shih